- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/90 - Oxygen atoms with acyclic radicals attached in position 2 or 3
Patent holdings for IPC class C07D 239/90
Total number of patents in this class: 160
10-year publication summary
|
5
|
8
|
7
|
4
|
8
|
7
|
12
|
5
|
5
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Inipharm, Inc. | 28 |
7 |
| Array BioPharma Inc. | 498 |
5 |
| ATIR Holding S.A. | 18 |
5 |
| Gilead Sciences, Inc. | 2056 |
5 |
| Hoffmann-La Roche Inc. | 3478 |
4 |
| Southern Research Institute | 210 |
4 |
| University of Kansas | 885 |
4 |
| University of Louisville Research Foundation, Inc. | 724 |
4 |
| Novartis AG | 10721 |
3 |
| F. Hoffmann-La Roche AG | 7948 |
3 |
| AstraZeneca AB | 2886 |
3 |
| AstraZeneca UK Limited | 625 |
3 |
| Pfizer Inc. | 3386 |
3 |
| Takeda Pharmaceutical Company Limited | 2710 |
3 |
| Ache International (BVI) Ltd. | 6 |
3 |
| ASKA Pharmaceutical Co., Ltd. | 102 |
3 |
| Oregon Health & Science University | 763 |
3 |
| prAna Biotechnology Limited | 13 |
3 |
| Morphic Therapeutic, Inc. | 51 |
3 |
| Amgen Inc. | 4108 |
2 |
| Other owners | 87 |